Litigation Details for THE MEDICINES COMPANY v. AUROBINDO PHARMA LIMITED (D.N.J. 2014)
✉ Email this page to a colleague
THE MEDICINES COMPANY v. AUROBINDO PHARMA LIMITED (D.N.J. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-04-11 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-11-22 |
| Cause | 35:271 Patent Infringement | Assigned To | Peter G. Sheridan |
| Jury Demand | None | Referred To | Douglas Arpert |
| Patents | 7,582,727; 7,598,343 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in THE MEDICINES COMPANY v. AUROBINDO PHARMA LIMITED
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for THE MEDICINES COMPANY v. AUROBINDO PHARMA LIMITED (D.N.J. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2014-04-11 | 1 | Code, involving United States Patent Nos. 7,582,727 (“the ’727 patent ”) (attached as Ex. A) and 7,598,343… 1. This is an action for patent infringement arising under the patent laws of the United States, …727 and ’343 patents a bivalirudin drug product that infringes the ’727 and /or ’343 patents. …727 and ’343 patents a bivalirudin drug product that infringes the ’727 and/or ’343 patents. …notifying a patent holder and the holder of the NDA for the drug that is claimed by the patent(s) or a use | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
